Fox Run Management’s Fulton Financial FULT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$266K Buy
+11,785
New +$282K 0.03% 788
2025
Q4
– Sell
-20,555
Closed -$383K – 1025
2025
Q3
$383K Sell
20,555
-3,104
-13% -$58.7K 0.06% 603
2025
Q2
$427K Buy
23,659
+7,280
+44% +$124K 0.07% 530
2025
Q1
$296K Buy
+16,379
New +$319K 0.05% 675
2024
Q1
– Sell
-14,353
Closed -$236K – 871
2023
Q4
$236K Buy
+14,353
New +$201K 0.06% 582
2023
Q1
– Sell
-14,316
Closed -$241K – 754
2022
Q4
$241K Sell
14,316
-9,372
-40% -$164K 0.1% 421
2022
Q3
$374K Buy
+23,688
New +$382K 0.15% 274
2019
Q1
– Sell
-10,101
Closed -$156K – 543
2018
Q4
$156K Sell
10,101
-16,678
-62% -$271K 0.08% 437
2018
Q3
$446K Buy
+26,779
New +$468K 0.19% 221
2018
Q1
– Sell
-28,125
Closed -$503K – 787
2017
Q4
$503K Buy
+28,125
New +$517K 0.15% 289

Other funds holding FULT

Fox Run Management's FULT Position: Q3 2026 in Review

Fox Run Management opened a new position in Fulton Financial (FULT) in Q3 2026: 11,785 shares worth $266K. The stake represents 0.03% of the portfolio and ranks #788 among its holdings. This is a return to the name: Fox Run Management previously reported a position in FULT as recently as Q3 2025.

Fox Run Management first reported a position in FULT in Q4 2017 and has held it in 10 quarters since. The position peaked at $503K in Q4 2017. 296 funds tracked by Wall St. Rank hold FULT as of Q3 2026.

  • Fox Run Management held 11,785 shares of Fulton Financial worth $266K as of Q3 2026.
  • Fulton Financial was a new Fox Run Management position in Q3 2026.
  • Fulton Financial made up 0.03% of Fox Run Management's portfolio in Q3 2026, its #788 holding.
  • Fox Run Management first reported a position in Fulton Financial in Q4 2017 and has held it in 10 quarters since.
  • Fox Run Management's Fulton Financial position peaked at $503K in Q4 2017.
  • 296 funds tracked by Wall St. Rank held Fulton Financial as of Q3 2026.

Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.